Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 3 | 9748191 | upstream gene variant | T/C | snv | 0.32 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
1.000 | 0.120 | 3 | 9753859 | intron variant | A/G | snv | 0.28 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Infections; Immune System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.280 | 3 | 9759396 | non coding transcript exon variant | G/A | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2013 | 2018 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2013 | 2018 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
Infections; Immune System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.280 | 3 | 9756456 | intron variant | C/G | snv | 0.28 | 0.24 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 3 | 9757429 | 3 prime UTR variant | A/G | snv | 0.22 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 |